Sign up
Pharma Capital

Orgenesis subsidiary MaSTherCell Global expanding into the US

Orgenesis Inc (NASDAQ:ORGS) subsidiary MaSTherCell Global CEO Derran Head tells Proactive Investors MaSTherCell is expanding into the US and building a new 30,000-square-foot manufacturing facility in Houston.

The Germantown, Maryland-based company’s subsidiary MaSTherCell Global is a leading cell and gene therapy global contract development and manufacturing organization, or CDMO.


View full ORGS profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.